News
FDA Suspends U.S. License of Chikungunya Vaccine
By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is suspending the biologics license for the live-attenuated chikungunya vaccine, Ixchiq, in the United States. The move comes after reports of serious side effects in older adults similar to the symptoms of chikungunya virus.
The cities of Foshan and Guangzhou, in southern China, have been battling the virus for two months. Nearly 10,000 cases have ...
DEAR DR. ROACH: I have a friend who lives in Paraguay and had been diagnosed with chikungunya. It has been extremely painful ...
Mosquito-borne chikungunya virus has caused an outbreak in China, but public health experts say the risk for spread and ...
Thousands in southern China have been infected with a mosquito-borne illness in the past few weeks, in what's considered one ...
Dear J.: Chikungunya may not sound like a real medical condition, but it is a viral disease that was first found in West ...
The war against the chikungunya virus that claims lives, which is dominant along the country’s coastal towns, has suffered a ...
There have been 33 locally-transmitted cases of the tropical disease in a neighborhood in the city of Vitrolles in the south ...
Chikungunya, a mosquito-borne viral infection, is witnessing a surge in reported cases across several regions, raising public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback